Join Drs Banerjee, Costa, and Nooka, as they review and discuss current and emerging safety and efficacy data of B-cell maturation antigen-directed bispecific antibody plus anti-CD38 monoclonal antibody combinations for the treatment of patients with relapsed/refractory multiple myeloma and practical considerations for the integration of this therapy into clinical practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- Haymarket Medical Education
Pricing
82% of listed courses are free
78 of 95 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiothoracic Surgery
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Otolaryngology
- General Pediatrics
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Medical Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Preventive Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Spine Surgery
- Urology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedMay 15, 2026
-
Last day to claim creditMay 16, 2027 7 months left
-
CancerNet +1 Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations
-
Haymarket Medical Education The Promise of Emerging CAR Ts in RRMM: Strategies to Improve Adoption in the Community
-
Haymarket Medical Education Exploring the Role of Minimal Residual Disease Status in Relapsed/Refractory Multiple Myeloma (Enduring)
